Limbic-Predominant Amnestic Neurodegenerative Syndrome: A Newly Recognized Memory Condition Distinct from Alzheimer's Disease
Limbic-predominant amnestic neurodegenerative syndrome (LANS) is a newly recognized memory condition that is distinct from Alzheimer's disease and primarily affects the limbic system, leading to a slow, amnestic, and predominantly neurodegenerative syndrome.
New Clinical Criteria Identify a Memory Disorder Often Misdiagnosed as Alzheimer's Disease
Newly proposed clinical criteria can help distinguish a memory loss disorder, limbic-predominant amnestic neurodegenerative syndrome (LANS), from Alzheimer's disease.
Tardive Dyskinesia: Causes, Symptoms, Diagnosis, and Treatment Options
Tardive dyskinesia is a chronic and progressive movement disorder caused by long-term use of antipsychotic medications, which can significantly impact patients' quality of life and daily functioning.
Pioneering Neurologist Shares Insights on Long COVID, POTS, and the Autonomic Nervous System
Svetlana Blitshteyn, a neurologist and expert on dysautonomia, shares her extensive experience in diagnosing and treating patients with Long COVID and POTS, highlighting the importance of the autonomic nervous system and the need for a multidisciplinary approach to these complex conditions.
Comprehensive Overview of Huntington's Disease: Diagnosis, Progression, Challenges, and Management
Huntington's disease is a progressive neurodegenerative disorder characterized by motor, cognitive, and psychiatric symptoms, caused by a genetic mutation affecting the HTT gene. Early diagnosis through genetic testing, multidisciplinary care, and emerging therapies are crucial for managing symptoms and improving quality of life for patients and their families.
Anti-Amyloid Drugs Linked to Brain Atrophy Risk
Anti-amyloid drugs used in Alzheimer's treatment may accelerate brain atrophy.
Lyme Meningitis and Emerging Neuroborreliosis Discussion
Lyme disease is an emerging pathogen with varying neurologic manifestations, primarily treated with oral doxycycline.
Myasthenia Gravis: Diagnosis and Immunopathogenesis Insights
Understanding the complexities of Myasthenia Gravis diagnosis and immunopathogenesis is crucial for effective patient management.
Retinal Thickness as a Predictor of MS Disability
Retinal thickness can predict MS disability.
NPTX2 Biomarker Predicts MCI Early
Low NPTX2 levels predict MCI onset.
© 2024 by Linnk AI